Theriva Biologics, Inc.

New Filing

CIK: 0000894158·Biotechnology·NEVADA·Filed: Oct 24, 2025

Total Offering

$13,109,494

Amount Sold

$13,109,494

Investors

10

First Sale

Oct 17, 2025

Offering Details

Type: Option to Acquire, Security to be Acquired
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Steven A. Shallcross	Related Person
Jeffrey J. Kraws	Related Person
John Monahan	Related Person
Jeffrey A. Wolf	Related Person

Company

Synthetic Biologics, Inc.

9605 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850

301-417-4364

SEC Filing

0001104659-25-101914

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.